Immunic, Inc. (IMUX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20264 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Immunic, Inc.’s names, not what it holds today.
2 published
4 published
Names not counted (2)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 6, 2014 | 8,715,954 | Method of producing C3A serum-free clonal cell line | Biotechnology | Vital Therapies, Inc. |
| Dec 17, 2013 | 8,608,953 | Metabolic detoxification system and method | Medical technology | Vital Therapies, Inc. |
| Jan 31, 2012 | 8,105,491 | Metabolic detoxification and method | Medical technology | Vital Therapies, Inc. |
| Jun 24, 2008 | 7,390,651 | C3A serum-free clonal cell line and methods of use | Biotechnology | Vital Therapies, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 21, 2019 | 2019/0350192 | USE OF CONDITIONED MEDIA FROM EXTRACORPOREAL BLOOD DETOXIFYING SYSTEM TO SUPPLEMENT ORGAN PERFUSION SOLUTIONS | Pharmaceuticals | Vital Therapies, Inc. |
| Oct 25, 2018 | 2018/0303995 | SYSTEM AND METHOD FOR EXTRACORPOREAL BLOOD TREATMENT | Medical technology | Vital Therapies, Inc. |
| Jul 5, 2018 | 2018/0185448 | COMPOSITION AND METHOD FOR INDUCING ANTI-INFLAMMATORY RESPONSE | Pharmaceuticals | Vital Therapies, Inc. |
| Jul 5, 2018 | 2018/0185446 | COMPOSITION AND METHOD FOR INDUCING ANTI-APOPTOSIS, SURVIVAL OR PROLIFERATION OF A CELL | Pharmaceuticals | Vital Therapies, Inc. |
| Aug 2, 2012 | 2012/0197174 | Metabolic Detoxification System and Method | Medical technology | Vital Therapies, Inc. · patent 8,608,953 granted from it |
| Feb 5, 2009 | 2009/0035805 | C3A Serum-Free Clonal Cell Line and Methods of Use | Biotechnology | Vital Therapies, Inc. · patent 8,715,954 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.